Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials

• Manu Shankar-Hari,
• Lise Estcourt,
• Heli Harvala,
• David Roberts,
• David K. Menon,
• On behalf of the United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium

Affiliations

Manu Shankar-Hari

School of Immunology & Microbial Sciences, Kings College London

Lise Estcourt

NHS Blood and Transplant, Level 2, John Radcliffe Hospital

Heli Harvala

National Microbiology Services, NHS Blood and Transplant

David Roberts

NHS Blood and Transplant, Level 2, John Radcliffe Hospital

David K. Menon

Division of Anaesthesia, Department of Medicine, University of Cambridge

On behalf of the United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium